Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Shares of Idenix Pharmaceuticals (IDIX -12.2%) sink after Abbott Laboratories (ABT +0.6%)...

  • Wednesday, April 4, 2012, 12:48 PM ET
    Shares of Idenix Pharmaceuticals (IDIX -12.2%) sink after Abbott Laboratories (ABT +0.6%) releases positive results from studies of its experimental hepatitis C treatment. Other Hep-C companies vying for a piece of the rapidly-growing multi-billion dollar market: Gilead Sciences (GILD -2.2%), Vertex Pharmaceuticals (VRTX -1.2%), Bristol-Myers Squibb (BMY -0.5%), BioCryst Pharmaceuticals (BCRX -3.4%).
Track new comments on this story

This news story has 1 comment:

  •  
    I would like to know where BMY stands in this hep research.Has anyone heard?
    5 Apr 2012, 12:22 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Articles
More Latest Articles »